Related references
Note: Only part of the references are listed.Aberrant Methylation of Death-Associated Protein Kinase 1 CpG Islands in Myelodysplastic Syndromes
Xueqiong Wu et al.
ACTA HAEMATOLOGICA (2011)
Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia
Elizabeth A. Griffiths et al.
EPIGENETICS (2010)
Epigenetic inactivation of tumour suppressor gene KLF11 in myelodysplastic syndromes
Anna Potapova et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
Lanlan Shen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Ying Jiang et al.
BLOOD (2009)
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
Dana E. Rollison et al.
BLOOD (2008)
Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome
Jiang Lin et al.
LEUKEMIA RESEARCH (2008)
Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome
Daniella B. Kerbauy et al.
EXPERIMENTAL HEMATOLOGY (2007)
Myelodysplastic syndromes - Incidence and survival in the United States
Xiaomei Ma et al.
CANCER (2007)
DNA methylation as a therapeutic target in cancer
Jean-Pierre J. Issa
CLINICAL CANCER RESEARCH (2007)
Myelodysplastic syndromes: the complexity of stem-cell diseases
Seth J. Corey et al.
NATURE REVIEWS CANCER (2007)
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference
Peter Valent et al.
LEUKEMIA RESEARCH (2007)
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
Hagop Kantarjian et al.
BLOOD (2007)
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
Shang-Ju Wu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Bruce D. Cheson et al.
BLOOD (2006)
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
H Kantarjian et al.
CANCER (2006)
ΔTAp73 upregulation correlates with poor prognosis in human tumors:: Putative in vivo network involving p73 isoforms, p53, and E2F-1
G Domínguez et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Promoter hypermethylation of p15(INK4B), HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients
A Aggerholm et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Decitabine activates specific caspases downstream of p73 in myeloid leukemia
I Tamm et al.
ANNALS OF HEMATOLOGY (2005)
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
L Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
被撤回的出版物: Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis (Retracted article. See vol. 31, pg. 979, 2013)
J Roman-Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
p73 induces apoptosis by different mechanisms
S Ramadan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia
K Schmelz et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
被撤回的出版物: Alteration of p73 in acute myelogenous leukemia (Retracted Article. See vol 83, pg 691, 2008)
GR Sahu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia
CG Ekmekci et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
被撤回的出版物: Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia (Retracted article. See vol. 113, pg. 2370, 2009)
J Roman-Gomez et al.
BLOOD (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia
DH Christiansen et al.
LEUKEMIA (2003)
The myelodysplastic syndrome(s): a perspective and review highlighting current controversies
DP Steensma et al.
LEUKEMIA RESEARCH (2003)
Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas
B Martinez-Delgado et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The World Health Organization (WHO) classification of the myeloid neoplasms
JW Vardiman et al.
BLOOD (2002)
Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients
U Germing et al.
LEUKEMIA RESEARCH (2000)
Share Paper
